-transparent.png){kind=logo}
Cultured human malignant melanoma cells, when added to normal human lymphocytes stimulated to proliferate by mitogen or antigen, were found to inhibit the uptake of 3H-thymidine (3H-T) by the lymphocytes. A heat-labile factor present in the supernatants of the melanoma cultures is responsible for inhibition. Cell viability and blastogenesis are unimpaired in the lymphocyte cultures containing the inhibitor. Inhibition of 3H-deoxyuridine uptake was also noted indicating that both salvage and de novo pathways of DNA synthesis are involved. Lymphocytes appear to be preferentially affected as cultured colon cancer cells take up 3H-T normally in the presence of the inhibitor. Normal mitotic indices and biochemical estimation of DNA content in lymphocyte cultures containing the inhibitory factor indicate that DNA synthesis does proceed normally. The mechanisms of action of the inhibitor would appear to involve alteration of exogenous nucleoside rather than a metabolic inhibition of intracellular nucleic acid synthesis.
V K Lui, and
P B Dent, and
S K Liao
January 1980,
Cell and tissue kinetics,
V K Lui, and
P B Dent, and
S K Liao
January 1986,
Advances in experimental medicine and biology,
V K Lui, and
P B Dent, and
S K Liao
January 1978,
Oncology,
V K Lui, and
P B Dent, and
S K Liao
February 1978,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
V K Lui, and
P B Dent, and
S K Liao
November 2022,
Anticancer research,
V K Lui, and
P B Dent, and
S K Liao
January 1969,
Verhandlungen der Deutschen Gesellschaft fur Pathologie,
V K Lui, and
P B Dent, and
S K Liao
January 1976,
International archives of allergy and applied immunology,
V K Lui, and
P B Dent, and
S K Liao
March 1977,
Transplantation,
V K Lui, and
P B Dent, and
S K Liao
August 1974,
Journal of immunology (Baltimore, Md. : 1950),
